Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 5, 2014
Dr. Jeff Sharman, medical director of hematology research at The US Oncology Network, shares his perspective on the many treatment options now available for patients with CLL and explores how smart combination therapies have revolutionized the way CLL is managed. Dr. Sharman examines the challenges that patient's face when making treatment decisions and discusses factors for patients to consider when choosing a treatment path. Produced in association with CLL Global Research Foundation